欧盟评估由粪肠球菌DSM 33761、乳酸片球菌DSM 33758和动物双歧杆菌DSM 16284等组成的饲料添加剂对育肥家禽的有效性

 　　  2025年5月26日，据欧盟食品安全局（EFSA）消息，应欧盟委员会要求，欧盟动物饲料添加剂和产品（FEEDAP）研究小组就由粪肠球菌DSM 33761、乳酸片球菌DSM 33758、动物双歧杆菌DSM 16284、罗伊氏乳杆菌DSM 33751和唾液联合乳杆菌DSM 16351组成的饲料添加剂对育肥家禽、饲养用于产蛋/繁殖家禽的有效性发表科学意见。 
　　部分原文报道如下：
 
　　Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the efficacy of Biomin® C5, which consists of a preparation containing viable cells of Enterococcus faecium DSM 33761, Pediococcus acidilactici DSM 33758, Bifidobacterium animalis DSM 16284, Limosilactobacillus reuteri DSM 33751 and Ligilactobacillus salivarius DSM 16351, as a zootechnical feed additive (functional group: gut flora stabilisers). The additive is intended to be used for chickens for fattening, chickens reared for laying, turkeys for fattening, turkeys reared for breeding and minor poultry species for fattening or reared for laying/breeding at a use level of 1 × 10⁸ CFU/kg complete feed or 5 × 10⁷ CFU/L in water for drinking. In a previous assessment, the FEEDAP Panel concluded that the additive is safe for the target species, consumers and the environment but could not conclude on its efficacy due to insufficient data. The applicant provided three long-term trials in chickens for fattening to address the data gaps in the efficacy assessment. based on the results of the trials in the previous and current applications, the FEEDAP Panel concluded that Biomin® C5 has the potential to be efficacious when supplemented either in the feed or water of chickens for fattening, and the conclusion was extrapolated to all poultry for fattening and reared for laying/breeding.